167 related articles for article (PubMed ID: 10728163)
1. Long-term treatment with acarbose for the treatment of reactive hypoglycemia.
Ozgen AG; Hamulu F; Bayraktar F; Cetínkalp S; Yilmaz C; Túzún M; Kabalak T
Eat Weight Disord; 1998 Sep; 3(3):136-40. PubMed ID: 10728163
[TBL] [Abstract][Full Text] [Related]
2. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
3. Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels.
Valderas JP; Ahuad J; Rubio L; Escalona M; Pollak F; Maiz A
Obes Surg; 2012 Apr; 22(4):582-6. PubMed ID: 22161170
[TBL] [Abstract][Full Text] [Related]
4. Effect of acarbose on glucose and insulin response to sucrose load in reactive hypoglycemia.
Richard JL; Rodier M; Monnier L; Orsetti A; Mirouze J
Diabete Metab; 1988; 14(2):114-8. PubMed ID: 3042485
[TBL] [Abstract][Full Text] [Related]
5. Acarbose in reactive hypoglycemia: a double-blind study.
Gérard J; Luyckx AS; Lefèbvre PJ
Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):25-31. PubMed ID: 6698657
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance.
Kentrup H; Bongers H; Spengler M; Kusenbach G; Skopnik H
Eur J Pediatr; 1999 Jun; 158(6):455-9. PubMed ID: 10378391
[TBL] [Abstract][Full Text] [Related]
7. [Alpha-glucosidase inhibitors: a new therapeutic approach in diabetes and functional hypoglycemia].
Brogard JM; Willemin B; Blicklé JF; Lamalle AM; Stahl A
Rev Med Interne; 1989; 10(4):365-74. PubMed ID: 2678346
[TBL] [Abstract][Full Text] [Related]
8. Acarbose and idiopathic reactive hypoglycemia.
Peter S
Horm Res; 2003; 60(4):166-7. PubMed ID: 14530603
[TBL] [Abstract][Full Text] [Related]
9. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.
Renard E; Parer-Richard C; Richard JL; Jureidini S; Orsetti A; Mirouze J
Diabete Metab; 1991; 17(3):355-62. PubMed ID: 1884880
[TBL] [Abstract][Full Text] [Related]
10. Impaired glucose homeostasis in young adult thalassemic patients: a pilot study with acarbose.
Mangiagli A; Italia S; De SV; Campisi S
J Pediatr Endocrinol Metab; 2002 Feb; 15(2):205-10. PubMed ID: 11874186
[TBL] [Abstract][Full Text] [Related]
11. Acarbose treatment of infant dumping syndrome: extensive study of glucose dynamics and long-term follow-up.
Zung A; Zadik Z
J Pediatr Endocrinol Metab; 2003; 16(6):907-15. PubMed ID: 12948306
[TBL] [Abstract][Full Text] [Related]
12. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
Rosak C; Hofmann U; Paulwitz O
Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
[TBL] [Abstract][Full Text] [Related]
13. Comparing the efficacy of α-glucosidase inhibitors in suppressing postprandial hyperglycemia using continuous glucose monitoring: a pilot study-the MAJOR study.
Tsujino D; Nishimura R; Taki K; Morimoto A; Tajima N; Utsunomiya K
Diabetes Technol Ther; 2011 Mar; 13(3):303-8. PubMed ID: 21291335
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic-pharmacodynamic relationships of Acarbose.
Salvatore T; Giugliano D
Clin Pharmacokinet; 1996 Feb; 30(2):94-106. PubMed ID: 8906894
[TBL] [Abstract][Full Text] [Related]
15. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
16. [Indication and side effect of alpha glucosidase inhibitor].
Katahira H; Ishida H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():399-408. PubMed ID: 12387025
[No Abstract] [Full Text] [Related]
17. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
[TBL] [Abstract][Full Text] [Related]
18. The use of acarbose in the prevention and treatment of hypoglycaemia.
Lefebvre PJ; Scheen AJ
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():40-4. PubMed ID: 8001627
[TBL] [Abstract][Full Text] [Related]
19. Postprandial reactive hypoglycemia in an oldest-old patient effectively treated with low-dose acarbose.
Tamura Y; Araki A; Chiba Y; Horiuchi T; Mori S; Hosoi T
Endocr J; 2006 Dec; 53(6):767-71. PubMed ID: 16966825
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
Hasegawa T; Yoneda M; Nakamura K; Ohnishi K; Harada H; Kyouda T; Yoshida Y; Makino I
J Gastroenterol Hepatol; 1998 Dec; 13(12):1201-6. PubMed ID: 9918426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
